News & Analysis on Clinical Trial Services & Contract Research And Development
Using quick disconnect couplings in fluid handling and manufacturing operations is the safest way to protect brand integrity by capturing fluid and product data from point of origin through point of use, according to a top Colbert expert.
Many said it couldn't be done, but Australian pharma firm Phosphagenics has developed what it claims is the world's first transdermal insulin formulation and has received the first signs that the product may have blockbuster potential.
Researchers believe that the effectiveness of from a commonly used asthma medicine may be compromised by a gene variation, which is present in around 13 per cent of the city's population.
CureTech has revealed it has wrapped up a deal in which Teva Pharmaceuticals will invest $6m (€4.7m) in CureTech, for the development of a revolutionary cancer drug, based on the company's potential value of $64m.
Drug companies have been encouraged by recent studies that suggest that by blocking the binding of transcription factors may be a way to short-circuit the harmful effects of diseases.
Following a recent report that predicted the use of apes in animal testing would be unavoidable in the future, Spain could become the first country worldwide to give some primate species fundamental rights that are granted to human beings.